New blood test may catch liver cancer earlier in High-Risk patients

This study is testing whether a new blood test called the GAAD score can find liver cancer earlier in people who are at high risk, such as those with cirrhosis or chronic hepatitis B. The GAAD score combines a patient's age, gender, and two blood markers (AFP and PIVKA-II) into a single result. Researchers will compare the GAAD score to standard ultrasound and AFP tests to see which approach catches more cancers with fewer false alarms. About 2,100 adults from Asia-Pacific countries will take part.